ADT Booster - Medsafe
Following vaccination with ADT™ Booster, the most common adverse reactions are redness and swelling at the injection site and fever. These reactions most commonly start within 48 hours from the day of vaccination.
Download ADT Booster - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Vaccine ingredients - Immunisation Advisory Centre
www.immune.org.nzVaccine ingredients ADT Booster Vaccine against diphtheria and tetanus diseases Type: Subunit, toxoid vaccine Ingredients Quantity/dose (0.5mL) Function
ADT Booster - immune.org.nz
www.immune.org.nzADT™ Booster Data Sheet Version 6 Page 1 . NAME OF THE MEDICINE . ADT™ Booster.Diphtheria and Tetanus Vaccine (adsorbed) for re-vaccination. DESCRIPTION ADT™ Booster is a suspension for intramuscular injection, containing aluminium-hydroxide-adsorbed diphtheria and tetanus toxoids.
ADT Booster (ay-dee-tee boo-ster) - Medsafe
www.medsafe.govt.nz1 ADT™ Booster (ay-dee-tee boo-ster) Diphtheria and Tetanus Vaccine, Adsorbed . Consumer Medicine Information What is in this leaflet . This leaflet answers some common questions about ADT™ Booster.. It does not contain all the available information.
BRAKE TESTING OF TRACKLESS MOBILE MINING …
www.mhsc.org.za1 Safety in Mines Research Advisory Committee Final Project Report BRAKE TESTING OF TRACKLESS MOBILE MINING MACHINERY RW Ottermann NDL Burger AJ von Wielligh
BUPERSINST 1780.1A PERS-675 BUPERS INSTRUCTION …
www.public.navy.milBUPERSINST 1780.1A PERS-675 5 Oct 2004 BUPERS INSTRUCTION 1780.1A From: Chief of Naval Personnel To: All Ships and Stations (less Marine Corps field